Abstract. The extent of thyroidectomy in Graves' disease is still controversial. In our institution, long term euthyroidism without thyroxine replacement therapy has been aimed and, thus, subtotal thyroidectomy has been employed. We prospectively studied whether the surgical outcome was improved by a strategy of leaving smaller thyroid remnants. Between 1989 and 1998, 1897 patients with Graves' disease were treated by subtotal thyroidectomy and their thyroid function could be determined 2 to 3 years after thyroidectomy. The 10-year period was divided into 3 parts, '89-'91 (Period 1, n = 690), '92-'94 (Period 2, n = 587) and '95-'98 (Period 3, n = 620). Different maximum thyroid remnant sizes were prospectively established for each period: up to 7 g left in Period 1, up to 6 g in Period 2 and up to 5 g in Period 3. Thyroid function 2 to 3 years after thyroidectomy and the occurrence of surgical complications were compared among the three groups. The relapse rate for Period 1, Period 2, and Period 3 was 14.1%, 12.6%, and 10.9%, respectively, and the rate of euthyroidism decreased and rate of hypothyroidism increased from period to period. Surgical complications increased in Periods 2 and 3. For preventing relapse, the strategy of reducing the thyroid remnant is effective. Subtotal thyroidectomy leaving 3-4 g remnant tissue is a suitable surgical option for Graves' disease.
ALTHOUGH treatment policy varies from country to country, surgical treatment of Graves' disease has not been considered first line therapy. The indications for surgical treatment depend on the preferences of patients, physicians, and society. In North America, radioiodine therapy is usually preferred over thyroidectomy for the majority of patients [1] . However, some reports [2, 3] from the United States have emphasized the advantages of thyroidectomy for Graves' disease and recommended thyroidectomy for selected patients. Thyroidectomy is more common in Asian countries than in North America and European countries. There are several advantages of thyroidectomy, and it has not been completely abandoned. Controversy also exists concerning whether subtotal or total thyroidectomy is more suitable as surgical therapy for Graves' disease. While no patients are expected to have a recurrence of hyperthyroidism after total thyroidectomy, all patients have permanent hypothyroidism and require thyroxin replacement therapy throughout their life. Subtotal thyroidectomy has been performed as a standard procedure for Graves' disease in Japan. Patients in our hospital seldom prefer to total thyroidectomy, and most patients choose subtotal thyroidectomy in expectation of the advantage of remission without medication. We previously reported our surgical outcome [4] , and the relapse rate of hyperthyroidism was too high to be accepted. Since the size of thyroid remnant is the most powerful factor that predicts postoperative relapse [5] [6] [7] , in the past decade, we prospectively and gradually changed thyroid remnant size to reduce the relapse rate.
In this paper we report our experiences with the treatment of Graves' disease by subtotal thyroidectomy during the past 10 years, analyze the surgical outcome, and assess whether the postoperative relapse rate was sufficiently improved and whether thyroidectomy still plays a role in the management of Graves' disease.
Materials and Methods

Patients
Between 1989 and 1998, 2249 patients with Graves' disease were treated by subtotal thyroidectomy at Ito Hospital. Of 2249 patients, 1897 patients (84.3%) could be followed more than 2 years after thyroidectomy, and they constituted the subjects of this study. There were 1519 females and 378 males, and their mean age was 26 years old (range: 5-67 years). The indications for thyroidectomy were 1) relapse of hyperthyroidism after several courses of medical treatment, in 37%, 2) large goiter size, in 34%, 3) patient's preference, in 20%, 4) pharmacological intolerance, in 5%, 5) coexistence with nodule, in 4%.
The 10 years of this study were divided into 3 periods: 1989-1991 (Period 1), 1992-1994 (Period 2), and 1995-1998 (Period 3). Since the follow-up periods differed among the 3 groups of patients, both thyroid function 2 or 3 years after thyroidectomy and the results of the most recent thyroid function tests during their follow-up periods were compared. The size of the remnant thyroid tissue was prospectively changed in each of the 3 periods: less than 7 g in Period 1, less than 6 g in Period 2, and less than 5 g in Period 3. The corresponding numbers of patients were 690, 587, and 620, respectively.
Surgical procedure
All patients were euthyroid at the time of thyroidectomy, and several experienced endocrine surgeons in our surgical division operated them on. Bilateral subtotal thyroidectomy (i.e., resection of the bilateral thyroid lobes with isthmus, leaving a small amount of the posterior rim of each lobe) was performed in all patients. Remnant thyroid was left widely and thinly to protect the parathyroid glands and the recurrent nerves. Thus, the recurrent nerve was not identified essentially. An attempt was made to leave all parathyroid glands in situ, but if resected, they were transplanted to the sternocleidomastoid muscle. Actually, parathyroid auto transplantation was performed in 38 patients. The size of the remnant thyroid was estimated by weighing a portion of the resected gland of the same size. We did not use the different surgical strategy in patients with coexistent thyroid nodules or with ophthalmopathy.
Evaluation of thyroid function
Thyroid function tests at the time of thyroidectomy and during the postoperative course consisted of serum FT3, FT4, TSH (thyrotropin), and TBII (TSH binding inhibitory immunoglobulin) determinations. FT3, FT4, and TSH were determined by chemiluminescent enzyme immunoassay with commercially available kits. TBII was measured by radioreceptor assay with a commercial kit (R.S.R. Limited, Cardiff, United Kingdom). The normal ranges are as follows: FT3: 3.8-8.4 pmol/L; FT4: 10.3-24.5 pmol/L, TSH: 0.3-3.5 mU/L; TBII: <10%. Postoperative thyroid status was evaluated mainly on the basis of TSH levels. Patients with a suppressed TSH level persisting for at least 6 months were classified as having recurrent hyperthyroidism, patients with a normal TSH were classified as euthyroid, and patients with an elevated TSH were classified as hypothyroid. A suppressed TSH level with normal thyroid hormone was diagnosed as latent hyperthyroidism, and a suppressed TSH level with elevated thyroid hormone was diagnosed as overt hyperthyroidism. Postoperative follow-up studies were performed at 1 month, 3 months, 6 months, 12 months, and every 6 months thereafter.
Risk factor analyses
Risk factors for recurrent hyperthyroidism were analyzed. The frequency and risk factors of surgical complications, such as postoperative hypocalcemia, hoarseness, and postoperative bleeding requiring reoperation, were also studied. Statistical analysis was by the chi-square test for univariate analysis. A significance level of p<0.05 was adopted. All data were calculated with computer software (JMP version 4.0; SAS Institute Inc., Cary, NC, USA). Table 1 shows the distributions of age, gender, thy-roid remnant size, resected thyroid weight, and preoperative TBII levels among the 3 periods. More elderly patients underwent thyroidectomy in Period 3, but the difference was not significant. Gender ratio, resected thyroid weight, and preoperative TBII level were almost the same among the 3 periods. Patients' background factors, except thyroid remnant size, were not significantly different among the 3 periods. Because of our strategy, thyroid remnant size was significantly different. The proportion of patients in whom our strategy was achieved was 95.8% in Period 1, 95.7% in Period 2, and 88.7% in Period 3, and the mean size of thyroid remnant was 5.0 g in Period 1, 4.3 g in Period 2, and 3.8 g in Period 3.
Results
Patients background
Surgical outcome
Thyroid function 2-3 years after thyroidectomy and thyroid function at the latest follow-up visit is shown in Table 2 . Two hundred thirty-eight patients (12.6%) had recurrent hyperthyroidism, including latent hyperthyroidism. Of these, 98 patients (5.2%) had overt hyperthyroidism requiring therapeutic options.
The comparison of thyroid function both at 2-3 years after thyroidectomy and at the latest follow-up visit among the 3 periods is shown in Fig. 1 . Recurrent hyperthyroidism was less frequent in Period 3. Recurrence rate at 2-3 years after thyroidectomy and at the latest follow-up visit were 14.1% and 22.0%, respectively in Period 1, which fell 10.8% and 11.5%, respectively in Period 3. Change of recurrence rate from Period 1 to Period 3 was about 23% decrease at 2-3 years after thyroidectomy and about 48% decrease (recurrence rate % for Period 1-recurrence rate for Period 3/recurrence rate for Period 1). On the other hand, the proportion of patients with euthyroidism also de- creased, and patients with hypothyroidism increased. From Period 1 to Period 3, euthyroidism at 2-3 years after thyroidectomy decreased 40% and hypothyroidism at 2-3 years after thyroidectomy increased 52%. The distribution of the estimated weights of the thyroid remnant in patients with recurrent hyperthyroidism in the 3 periods is shown in Fig. 2 . In accordance with our prospective strategy to decrease remnant thyroid size, the estimated remnant thyroid weight of the patients with recurrent hyperthyroidism decreased from period to period. None of the patients with a thyroid remnant that weighed less than 2 g developed recurrent hyperthyroidism.
Risk factor analyses for recurrent hyperthyroidism
Risk factors analyzed for recurrent overt hyperthyroidism were: age at thyroidectomy, gender, weight of resected thyroid tissue, weight of the thyroid remnant, and preoperative TBII level. Histological findings were excluded because they become clear only after thyroidectomy. Significant factors related to postoperative hyperthyroidism were gender, weight of the thyroid remnant, and preoperative TBII level (Table 3) . Although females had significantly smaller thyroid remnant size (mean size 4.3 ± 1.2) than males (mean size 4.8 ± 1.3), recurrent hyperthyroidism was more frequently in the females. Recurrence was more frequent in patients with younger age and larger goiter, however, the differences were not significant.
Surgical complications and risk factor analyses
Surgical complications, such as postoperative hypocalcemia (hypoparathyroidism), hoarseness (recurrent nerve palsy), and postoperative bleeding requiring reoperation, were considered major complications. The serum calcium, phosphate, and albumin levels of all patients were measured on the day after thyroidectomy. Two hundred fifty-seven patients (13.5%) had postoperative hypocalcemia that required oral calcium supplementation with or without calcitriol. All patients except 2 had transient hypocalcemia and recovered within 6 months after thyroidectomy. One hundred twenty-one patients (6.4%) had postoperative hoarseness that was transient in every case and recovered within 6 months after thyroidectomy. The rates of these complications were compared among the 3 periods, and they are summarized in Table 4 . Postoperative hypocalcemia increased significantly in Periods 2 Table 5 and 6. Factors analyzed were age, gender, resected thyroid weight, estimated remnant thyroid weight, and intraoperative blood loss. Significant factors related to postoperative hypocalcemia were age, gender, resected thyroid weight, and intraoperative blood loss. Estimated remnant thyroid weight was not a significant risk factor for postoperative hypocalcemia. Significant factors related the postoperative hoarseness were resected thyroid weight and intraoperative blood loss.
Discussion
The treatment policy for Graves' disease varies from country to country and institution to institution [8] [9] [10] . Radioiodine therapy is currently the treatment of choice for most adults with Graves' disease and has been successfully employed to treat childhood Graves' disease in several institutions. There are some articles suggesting that radioiodine treatment for Graves' disease 1) increases the risk of benign thyroid nodules [11] , 2) increases the risk of hyperparathyroidism [12] , and 3) slightly increases the risk of more aggressive thyroid cancer [13] . Radioiodine treatment has become popular in recent years in Japan, however, the strict safety rules and patients' radiation phobia prevent its widespread adoption [14] . Thyroidectomy is often performed in patients with a large goiter, as a secondary treatment when antithyroid medication fails, younger patients, and patients who hope for immediate remission. What is the therapeutic goal of the surgical treatment of Graves' disease? We think the ideal goal is not euthyroidism with thyroxin replacement therapy, but long-term euthyroidism without medication. Factors related to postoperative thyroid dysfunction, especially recurrent hyperthyroidism, had to be elucidated to achieve this goal and we have published several reports and concluded that thyroid remnant size is the only powerful factor related to postoperative thyroid dysfunction [4, 15] . Risk factor analyses showed that female patients with high preoperative TBII level had recurrent overt hyperthyroidism. In our previous report [4] , 18% of patients with Graves' disease treated by subtotal thyroidectomy had developed recurrent hyperthyroidism after 8 years postoperatively, and that was not a satisfactory result. Since we routinely left thyroid remnant with an estimated weight 6 g to 8 g in those days, we need to leave a smaller thyroid remnant to decrease the recurrence rate and therefore prospectively and gradually decrease the size of the remnant. Based on the outcome 2 to 3 years after thyroidectomy, the postoperative relapse rate did decrease, but an increase in patients with hypothyroidism and decrease in euthyroid patients was also observed. The effect of the decreasing thyroid remnant strategy on the recurrence rate from Period 1 to Period 3 was a 23% decrease, and effect on hypothyroidism during the same period was a more than 50% increase. A one percent decrease in rate of recurrence would be associated with a more than two percent increase in hypothyroidism rate. The surgical complications of thyroidectomy for Graves' disease should be low at any age, and the over-all frequency of permanent surgical complications in our series was almost the same as in previous reports [16] . An increasing rate of the surgical complications, especially postoperative hypocalcemia, was observed in Periods 2 and 3. The risk factor analyses showed that postoperative hypocalcemia was observed more frequently in younger female patients with larger goiters and larger intraoperative blood loss. Patients with smaller remnant size also had a higher rate of postoperative hypocalcemia, although the difference was not significant. The proportion of patients with more than 400 g intraoperative blood loss in Period 1, Period 2, and Period 3 was 16.5%, 22.1%, and 27.4%, respectively. Because more patients with a smaller thyroid remnant and greater blood loss were included in Periods 2 and 3, more patients with hypocalcemia were observed in these periods.
From our results, reducing the thyroid remnant is an ideal strategy preventing recurrent hyperthyroidism. However, to prevent recurrence, it is difficult to assess retrospectively how small a thyroid remnant should have been left for patients with recurrent hyperthyroidism. We now leave a 3 g to 4 g thyroid remnant when patients prefer subtotal thyroidectomy. When a 3 g to 4 g thyroid remnant was left, in this study, the overt recurrence rate 2 to 3 years after thyroidectomy was about 4%. Whether all patients can accept this recurrence rate, is uncertain. Neither subtotal thyroidectomy nor total thyroidectomy would be an ideal surgical procedure for Graves' disease. Both procedures have advantages and disadvantages. Total thyroidectomy calls for thyroxin replacement therapy throughout the patient's life, and subtotal thyroidectomy entails the risk of recurrence at the rates stated in this report. However, patients with recurrent hyperthyroidism can be treated with rather small doses of radioiodine as we previously reported [17] , and postoperative hypothyroidism can be controlled easily with thyroxin. Informed consent to treat patients with Graves' disease should include discussion of the advantages and disadvantages of both subtotal and total thyroidectomy. Subtotal thyroidectomy should be recommended only when they want to avoid permanent hypothyroidism as far as possible and they can accept risk of recurrence to some extent.
